Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s): DNABW

Chemicals Specialty Chemicals

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.

NYSE:DNA - Post by User

Ginkgo Bioworks Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Paray99on Jul 10, 2024 10:38pm

120 Views

Post# 36127626

Worst investment!

Now I understood that Cathie wood is a pure gambler.... she ended her gambling in DNA and sold everything with huge loss. So the lesson learned .... Cathie Wood knows nothing about the companies she invested! Now she started selling Tesla.... ha ha ha....

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China